(EWSP) SP500 Equal Weight USD - Overview
Etf: Equity, Equal-Weight, Large-Cap, Mid-Cap
| Risk 5d forecast | |
|---|---|
| Volatility | 11.5% |
| Relative Tail Risk | -3.82% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.68 |
| Alpha | 7.09 |
| Character TTM | |
|---|---|
| Beta | 0.182 |
| Beta Downside | 0.288 |
| Drawdowns 3y | |
|---|---|
| Max DD | 18.39% |
| CAGR/Max DD | 0.71 |
Description: EWSP SP500 Equal Weight USD January 12, 2026
The iShares S&P 500 Equal Weight UCITS ETF (Acc) (ticker EWSP) is a Netherlands-domiciled exchange-traded fund that tracks the Morningstar US Large-Mid NR USD index, delivering an equal-weight exposure to the 500 largest U.S. equities. Its expense ratio sits at 0.20 % and the fund distributes earnings on an accumulating basis, resulting in a trailing-12-month net yield of roughly 1.6 % (as of Dec 2025). Total assets under management are about €12 bn, with an average turnover of 15 % per year, reflecting the periodic rebalancing required to maintain equal weighting.
Because each constituent receives roughly the same capital allocation, the ETF tilts away from the market-cap bias that favours mega-cap technology stocks, giving relatively higher exposure to sectors such as industrials, consumer staples and utilities. In the current macro environment, the fund’s performance is driven by three measurable factors: (1) U.S. consumer-spending trends, which underpin earnings for the broad-based retail and services components; (2) the Federal Reserve’s monetary stance-particularly the pace of rate cuts, which tends to benefit cyclical sectors; and (3) the earnings growth outlook for mid-cap innovators in health-care and clean-energy, which are more heavily weighted in an equal-weight construct than in a cap-weighted S&P 500.
If you want a data-rich, side-by-side comparison of EWSP’s risk-adjusted returns versus traditional cap-weighted S&P 500 ETFs, a quick look at ValueRay’s analytics dashboard can help you spot any hidden alpha opportunities.
What is the price of EWSP shares?
Over the past week, the price has changed by +1.34%, over one month by +2.55%, over three months by +7.99% and over the past year by +13.39%.
Is EWSP a buy, sell or hold?
What are the forecasts/targets for the EWSP price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 7.9 | 9.1% |
EWSP Fundamental Data Overview February 03, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 4.07b USD (4.07b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 4.07b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 4.07b / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 6.58% (E(4.07b)/V(4.07b) * Re(6.58%) + (debt-free company))
Discount Rate = 6.58% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Fair Price DCF = unknown (Cash Flow 0.0)